Reconstitution of Cyclin D1-Associated Kinase Activity Drives Terminally Differentiated Cells into the Cell Cycle

REFERENCES

• Bain, G., and D. I. Gottlieb. 1998. Neural cells derived by in vitro differentiation of P19 and embryonic stem cells. Perspect. Dev. Neurobiol. 5:175–178.
   PubMedGoogle Scholar
• Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91:8802–8806.
   PubMed Web of Science ®Google Scholar
• Blau, H. M., G. K. Pavlath, E. C. Hardeman, C.-P. Chiu, L. Silberstein, S. G. Webster, S. C. Miller, and C. Webster. 1985. Plasticity of the differentiated state. Science 230:758–766.
   PubMed Web of Science ®Google Scholar
• Cardoso, M. C., H. Leonhardt, and B. Nadal-Ginard. 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74:979–992.
   PubMedGoogle Scholar
• Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation Mol. Biol. Cell 8:287–301.
   Google Scholar
• Crescenzi, M., S. Soddu, A. Sacchi, and F. Tató. 1995. Adenovirus infection induces reentry into the cell cycle of terminally differentiated skeletal muscle cells. Ann. N. Y. Acad. Sci. 752:9–18.
   PubMedGoogle Scholar
• Crescenzi, M., S. Soddu, and F. Tató. 1995. Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection. J. Cell. Physiol. 162:26–35.
   PubMedGoogle Scholar
• Endo, T., and B. Nadal-Ginard. 1989. SV40 large T antigen induces reentry of terminally differentiated myotubes into the cell cycle. Cellular and molecular biology of muscle development.. L. H. Kedes, and F. E. Stockdale. 95–104. Alan R. Liss, Inc., New York, N.Y
   Google Scholar
• Fogel, M., and V. Defendi. 1967. Infection of muscle cultures from various species with oncogenic DNA viruses (SV40 and polyoma). Proc. Natl. Acad. Sci. USA 58:967–973.
   PubMedGoogle Scholar
• Geng, Y., W. Whoriskey, M. Y. Park, R. T. Bronson, R. H. Medema, T. Li, R. A. Weinberg, and P. Sicinski. 1999. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97:767–777.
   PubMed Web of Science ®Google Scholar
• Gomez Lahoz, E., N. J. Liegeois, P. Zhang, J. A. Engelman, J. Horner, A. Silverman, R. Burde, M. F. Roussel, C. J. Sherr, S. J. Elledge, and R. A. DePinho. 1999. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol. Cell. Biol. 19:353–363.
   PubMedGoogle Scholar
• Green, H., and M. Meuth. 1974. An established pre-adipose cell line and its differentiation in culture. Cell 3:127–133.
   PubMed Web of Science ®Google Scholar
• Haas, K., P. Staller, C. Geisen, J. Bartek, M. Eilers, and T. Moroy. 1997. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene 15:179–192.
   PubMed Web of Science ®Google Scholar
• Haley, K. P., J. Overhauser, L. E. Babiss, H. S. Ginsberg, and N. C. Jones. 1984. Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products. Proc. Natl. Acad. Sci. USA 81:5734–5738.
   PubMedGoogle Scholar
• Harrison, T., F. L. Graham, and J. Williams. 1977. Host-range mutant of adenovirus type 5 defective for growth in HeLa cells. Virology 77:319–329.
   PubMed Web of Science ®Google Scholar
• He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Hiyama, H., A. Iavarone, J. LaBaer, and S. Reeves. 1997. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 14:2533–2542.
   PubMedGoogle Scholar
• Kirshenbaum, L. A., and M. D. Schneider. 1995. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J. Biol. Chem. 270:7791–7794.
   PubMed Web of Science ®Google Scholar
• Kitagawa, M., H. Higashi, H. K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060–7069.
   PubMed Web of Science ®Google Scholar
• Ladha, M. H., K. Y. Lee, T. M. Upton, M. F. Reed, and M. E. Ewen. 1998. Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18:6605–6615.
   PubMed Web of Science ®Google Scholar
• Latella, L., A. Sacchi, and M. Crescenzi. 2000. Long-term fate of terminally differentiated skeletal muscle cells following E1A-initiated cell cycle reactivation. Cell Death Differ. 7:145–154.
   PubMedGoogle Scholar
• Latham, K. M., S. W. Eastman, A. Wong, and P. W. Hinds. 1996. Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases. Mol. Cell. Biol. 16:4445–4455.
   PubMedGoogle Scholar
• Leone, G., J. DeGregori, L. Jakoi, J. G. Cook, and J. R. Nevins. 1999. Collaborative role of E2F transcriptional activity and G1 cyclin-dependent kinase activity in the induction of S phase. Proc. Natl. Acad. Sci. USA 96:6626–6631.
   PubMedGoogle Scholar
• Liu, Y., and R. N. Kitsis. 1996. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J. Cell Biol. 133:325–334.
   PubMedGoogle Scholar
• Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479–1492.
   PubMed Web of Science ®Google Scholar
• Lundberg, A. S., and R. A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753–761.
   PubMed Web of Science ®Google Scholar
• Mal, A., D. Chattopadhyay, M. K. Ghosh, R. Y. Poon, T. Hunter, and M. L. Harter. 2000. p21 and Retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells. J. Cell Biol. 149:281–292.
   PubMedGoogle Scholar
• McBurney, M. W.. 1993. P19 embryonal carcinoma cells. Int. J. Dev. Biol. 37:135–140.
   PubMed Web of Science ®Google Scholar
• Morassutti, D. J., W. A. Staines, D. S. Magnuson, K. C. Marshall, and M. W. McBurney. 1994. Murine embryonal carcinoma-derived neurons survive and mature following transplantation into adult rat striatum. Neuroscience 58:753–763.
   PubMedGoogle Scholar
• Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135:441–456.
   PubMed Web of Science ®Google Scholar
• Odelberg, S. J., A. Kollhoff, and M. T. Keating. 2000. Dedifferentiation of mammalian myotubes induced by msx1. Cell 103:1099–1109.
   PubMed Web of Science ®Google Scholar
• Okazaki, K., and H. Holtzer. 1966. Myogenesis: fusion, myosin synthesis, and the mitotic cycle. Proc. Natl. Acad. Sci. USA 56:1484–1490.
   PubMed Web of Science ®Google Scholar
• Pajalunga, D., D. Tognozzi, M. Tiainen, M. D'Angelo, F. Ferrantelli, K. Helin, A. Sacchi, and M. Crescenzi. 1999. E2F activates late-G1 events but cannot replace E1A in inducing S phase in terminally differentiated skeletal muscle cells. Oncogene 18:5054–5062.
   PubMedGoogle Scholar
• Puri, P. L., L. Cimino, M. Fulco, C. Zimmerman, N. B. La Thangue, A. Giordano, A. Graessmann, and M. Levrero. 1998. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res. 58:1325–1331.
   PubMed Web of Science ®Google Scholar
• Rando, T. A., and H. M. Blau. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1275–1287.
   PubMed Web of Science ®Google Scholar
• Rao, S. S., C. Chu, and S. D. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259–5267.
   PubMedGoogle Scholar
• Reznikoff, C. A., D. W. Brankow, and C. Heidelberger. 1973. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33:3231–3238.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
   Google Scholar
• Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb−/− muscle cells. Science 264:1467–1471.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Skapek, S. S., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022–1024.
   PubMed Web of Science ®Google Scholar
• Soonpaa, M. H., G. Y. Koh, L. Pajak, S. Jing, H. Wang, M. T. Franklin, K. K. Kim, and L. J. Field. 1997. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J. Clin. Investig. 99:2644–2654.
   PubMed Web of Science ®Google Scholar
• Staines, W. A., D. J. Morassutti, K. R. Reuhl, A. I. Ally, and M. W. McBurney. 1994. Neurons derived from P19 embryonal carcinoma cells have varied morphologies and neurotransmitters. Neuroscience 58:735–751.
   PubMedGoogle Scholar
• Stocum, D. L.. 1997. New tissues from old. Science 276:15
   PubMedGoogle Scholar
• Tató, F., S. Alema, A. Dlugosz, D. Boettiger, H. Holtzer, G. Cossu, and M. Pacifici. 1983. Development of ‘revertant’ myotubes in cultures of Rous sarcoma virus transformed avian myogenic cells. Differentiation 24:131–139.
   PubMedGoogle Scholar
• Tiainen, M., D. Pajalunga, F. Ferrantelli, S. Soddu, G. Salvatori, A. Sacchi, and M. Crescenzi. 1996. Terminally differentiated skeletal myotubes are not confined in G0, but can enter G1 upon growth factor stimulation. Cell Growth Differ. 7:1039–1050.
   PubMedGoogle Scholar
• Tiainen, M., D. Spitkovsky, P. Jansen-Dürr, A. Sacchi, and M. Crescenzi. 1996. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol. Cell. Biol. 16:5302–5312.
   PubMedGoogle Scholar
• van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050–2054.
   PubMed Web of Science ®Google Scholar
• Wersto, R. P., E. R. Rosenthal, P. K. Seth, N. T. Eissa, and R. E. Donahue. 1998. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J. Virol. 72:9491–9502.
   PubMed Web of Science ®Google Scholar
• Yaffe, D., and D. Gershon. 1967. Multinucleated muscle fibres: induction of DNA synthesis and mitosis by polyoma virus infection. Nature 215:421–424.
   PubMedGoogle Scholar
• Zarkowska, T., and S. Mittnacht. 1997. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272:12738–12746.
   PubMed Web of Science ®Google Scholar
• Zhang, J. M., Q. Wei, X. Zhao, and B. M. Paterson. 1999. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J. 18:926–933.
   PubMedGoogle Scholar
• Zhang, J. M., X. Zhao, Q. Wei, and B. M. Paterson. 1999. Direct inhibition of G1 cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J. 18:6983–6993.
   PubMedGoogle Scholar